Literature DB >> 25932972

Acute acalculous cholecystitis (AAC) in the pediatric population associated with Epstein-Barr Virus (EBV) infection. Case report and review of the literature.

Fuad Alkhoury1, Diego Diaz1, Jesus Hidalgo2.   

Abstract

BACKGROUND: Epstein Barr Virus (EBV) is a ubiquitous herpes virus that persists lifelong in normal humans by colonizing memory B cells. Infection during childhood is usually asymptomatic. Isolated gallbladder wall thickening or hydrops have been reported in patients with EBV infectious mononucleosis. However, acute acalculous cholecystitis is an atypical clinical presentation of primary EBV infection. We present a teenager with acute cholecystitis associated with EBV acute infection. Acute acalculous cholecystitis accounts for 2-15% of all cases of acute cholecystitis. Few cases of acute cholecystitis have been reported during the course of primary EBV infection. PRESENTATION OF CASE: A 15-year-old female who came to the JDCH ER complaining of 3 days history of mild diffuse abdominal pain associated with two episodes of emesis. She also reports headache as well as a mild cough and low grade subjective fever. Blood test results showed mild leukocytosis with significant elevation in the lymphocytes (59%), High alkaline phosphatase (221 U/I), AST (191 U/I), ALT(221 U/I) and bilirubin (Total 1.8 and direct 1.5). Abdominal US showed a contracted gallbladder with wall thickness and pericholecystic fluid. During hospital stay number 2-3 laboratory work up show a trending up in the bilirubin levels. MRCP was ordered and no abdnormalities were found. At this point Hospital stay number 3 EBV acute infection was suspected. Serum serological studies were subsequently diagnostic for this viral disease. Management was conservative and the patient was discharged asymptomatic on hospital day number six.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acalculous cholecystitis; Acute cholecystitis; Childhood; Epstein Barr Virus; Mononucleosis

Year:  2014        PMID: 25932972      PMCID: PMC4446661          DOI: 10.1016/j.ijscr.2014.06.006

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Background

Epstein Barr Virus (EBV) is a ubiquitous herpes virus that persists lifelong in normal humans by colonizing memory B cells. Infection during childhood is usually asymptomatic, whereas it presents as typical infectious mononucleosis in about 50% of adolescents and young adults. Isolated gallbladder wall thickening or hydrops have been reported in patients with EBV infectious mononucleosis. However, acute acalculous cholecystitis is an atypical clinical presentation of primary EBV infection. We present a teenager with acute cholecystitis associated with EBV acute infection successfully treated with medical management. Acute acalculous cholecystitis accounts for 2–15% of all cases of acute cholecystitis. It is most commonly associated with trauma, recent surgery, shock, burns, sepsis, critical illness, total parental nutrition and prolonged fasting. Only 13 cases of acute cholecystitis have been reported during the course of primary EBV infection, of these cases, 12 were in female patients with ages ranging from 18 to 53 years old. Of those only one requires surgical intervention.

Case report

A 15-year-old female without significant past medical history came to the JDCH emergency room complaining of 3 days history of mild diffuse abdominal pain mainly in the epigastric region, constant, cramping/sharp, 7/10 in intensity associated with two episodes of non-bilious, non-bloody emesis. She also reports headache as well as a mild cough and low grade subjective fever. Blood test results showed mild elevated white blood cells count (10.95 × 10) with significant elevation in the lymphocytes (59%), High serum concentration of alkaline phosphatase (221 U/I), aspartate aminotransferase (191 U/I), alanine aminotransferase(221 U/I) and bilirubin (Total 1.8 and direct 1.5). Abdominal ultrasound showed a contracted gallbladder with wall thickness (19 mm) with pericholecystic fluid. Normal common bile duct (Figs. 1 and 2). CT imaging revealed similar findings with marked pericholecystic fluid. No visceromegaly. Moderate free fluid in the pelvis (Fig. 3). During hospital stay number 2–3 laboratory work up show a trending up in the bilirubin levels up to (Total 2.3 μmol/L and Direct 1.8 μmol/L). MRCP was ordered to rule out biliary obstruction and no choledocholithiasis nor intra or extra hepatobiliary duct dilation was found. No gallstone seen. At this point Hospital stay number 3 Epstein–Barr Virus (EBV) acute infection was suspected. Serum serological studies were subsequently diagnostic for this viral disease (both heterophile antibody test and IgM against EBV capsid antigen). There was no evidence of other coexisting infectious disease. Management was conservative and the patient was discharged asymptomatic on hospital day number six.
Fig. 3

MRCP.

Discussion

EBV is known to be one of the causes of infectious hepatitis. Mild transient elevation in the serum aminotransferases have been previously reported and mild jaundice is described in approximately 5% of the cases, possibly caused by cholestasis or maybe by virus-induced hemolysis. The association between EBV infection and ACC has been previously reported, but it was described as an uncommon event. AAC is an inflammatory process of the gallbladder in the absence of gallstones. The disease is rare in childhood and most cases occur during the course of infectious diseases. Other etiologies included major cardiac or abdominal surgery, burns and prolonged parental nutrition. Criteria such as gallbladder wall thickening of over 3 mm, distention of the gallbladder, localized tenderness and pericolecystic fluid and sludge have been used for the diagnosis of ACC. The combination of two or more of the above criteria, in the appropriate clinical setting, is considering being diagnostic. Taking in consideration the sporadic presentation off ACC, the etiologic pattern and clinical spectrum of the disease in childhood have not been well established. Sixteen cases of ACC associated with isolated primary EBV infection have been described. Four of those in the pediatric population. In all reports, ACC subsided during the regression of the EBV infection without needing of surgical intervention. Our new patient presented with the clinical picture of Acute Cholecystitis and possible biliary obstructive pattern. Serologic test confirmed the primary EBV infection. ACC has an excellent prognosis, subsiding gradually during the regression of the infectious mononucleosis, as happened in most of the previous reported cases in the literature. The exact pathogenesis of ACC remains uncertain, the main cause is thought to be bile stasis and increased lithogenicity of bile, resulting in gallbladder inflammation. Recently in the literature EBV-induced hepatitis has been recognized as an important cause of cholestasis. Our patient had cholestatic hepatitis due to confirmed EBV infection. Therefore the previous cases presented and our case supports the role of bile stasis in the pathogenesis of ACC, and also may suggest a possible role for acute EBV-infection as a possible role inducing cholestasis. The presence of Gilbert's syndrome in patients with cholestasis of infectious origin (EBV-infection) could also play a role in the development of gallbladder abnormalities. The incidence of Gilbert's syndrome may contribute in the pathogenesis of ACC in children with EBV infection. Guala et al., who studied selected hospitalized pediatric patients, reported that EBV might impair liver function mostly in individuals homozygous or heterozygous for the UGT1A1*28 mutation. They also reported that a more severe clinical course of EBV infection could be expected as a consequence of this genetic variation. Hepatic involvement and the subsequent cholestasis during EBV infection are seen more often in individuals with Gilbert's syndrome. In the review of the literature 17 cases (including the present report) of EBV-associated ACC were collected. All cases were described between 2007 and 2013. In general all patients showed similar clinical manifestations. Hyperbilirubinemia and moderate transaminase level elevation were the most common associated laboratory findings. Ultrasound findings of wall thickening were between 6 and 15 mm. Only one patient (21 years old) reported in 2009 by Hagel et al. underwent cholecystectomy as a definite treatment.

Conclusion

Acute acalculous cholecystitis (ACC) may occur during the course of EBV infection in the pediatric population. Most of the cases reported were treated with medical management. First time diagnosis may be challenging; clinical and hematological parameters of viral infection are helpful in forming diagnostic suspicious. EBV infection need to be considered early in the differential diagnosis of ultrasound findings of ACC.

Conflict of interest

None.

Funding

None.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Author contribution

Literature review: Jesus Hidalgo. Writing: Jesus Hidalgo, Fuad Alkhoury and Diego Diaz. Reviewing: Diego Diaz.

Key learning points

Key Learning Points We ask that you provide concise bullet points that clearly state the key learning points from your work. Acute acalculous cholecystitis Mononucleosis Epstein Barr virus Gallbladder Ultrasound
  11 in total

Review 1.  Acute complications of Epstein-Barr virus infectious mononucleosis.

Authors:  H B Jenson
Journal:  Curr Opin Pediatr       Date:  2000-06       Impact factor: 2.856

Review 2.  Epstein-Barr virus-recent advances.

Authors:  Karen F Macsween; Dorothy H Crawford
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

3.  Lethal liver failure in an elderly patient with hepatitis B superinfected with Epstein-Barr virus.

Authors:  M Jiménez-Sáenz; J M Pérez-Pozo; A Leal-Luna; J M Herrerías-Gutiérrez
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-11       Impact factor: 2.566

4.  Are Gilbert's syndrome and liver involvement genetically linked in infectious mononucleosis?

Authors:  Andrea Guala; Daniela Campra; Italo Marinelli; Gianluca Gaidano; Leonardo Pagani
Journal:  Pediatr Infect Dis J       Date:  2003-12       Impact factor: 2.129

5.  Epstein-Barr virus infectious mononucleosis associated with acute acalculous cholecystitis.

Authors:  E Lagona; F Sharifi; A Voutsioti; A Mavri; M Markouri; A Attilakos
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

6.  Gallbladder wall thickening in infectious mononucleosis: an ominous sign.

Authors:  N O'Donovan; E Fitzgerald
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

7.  Hepatic manifestations of Epstein-Barr viral infection.

Authors:  Nahum Méndez-Sánchez; Cecilia Aguilar-Domínguez; Norberto C Chávez-Tapia; Misael Uribe
Journal:  Ann Hepatol       Date:  2005 Jul-Sep       Impact factor: 2.400

8.  Acalculous cholecystitis in children.

Authors:  D E Tsakayannis; H P Kozakewich; C W Lillehei
Journal:  J Pediatr Surg       Date:  1996-01       Impact factor: 2.545

Review 9.  Acute acalculous cholecystitis during the course of primary Epstein-Barr virus infection: a new case and a review of the literature.

Authors:  Chiara Iaria; Lucia Arena; Giovanni Di Maio; Maria Grazia Fracassi; Maria Silvana Leonardi; Ciro Famulari; Antonio Cascio
Journal:  Int J Infect Dis       Date:  2008-02-20       Impact factor: 3.623

10.  Epstein-Barr virus - associated acute acalculous cholecystitis in an adult.

Authors:  Valentina Beltrame; Antoluigi Andres; Federico Tona; Cosimo Sperti
Journal:  Am J Case Rep       Date:  2012-07-12
View more
  12 in total

1.  Acalculous acute cholecystitis during the course of an enteroviral infection.

Authors:  Ana Sofia Simões; Andreia Marinhas; Paulo Coelho; Sandra Ferreira
Journal:  BMJ Case Rep       Date:  2019-04-11

2.  Acute acalculous cholecystitis in a Lebanese girl with primary Epstein-Barr viral infection.

Authors:  Marianne Majdalani; Nadine Milad; Zeyad Sahli; Sarah Rizk
Journal:  BMJ Case Rep       Date:  2016-04-18

3.  Acute Acalculous Cholecystitis by Epstein-Barr Virus Infection: A Rare Association.

Authors:  Liliana Branco; Maria Vieira; Cristiana Couto; Maria D Coelho; Carla Laranjeira
Journal:  Infect Dis Rep       Date:  2015-12-22

4.  Acute Acalculous Cholecystitis: A Rare Presentation of Primary Epstein-Barr Virus Infection in Adults-Case Report and Review of the Literature.

Authors:  Zuhal Yesilbag; Asli Karadeniz; Fatih Oner Kaya
Journal:  Case Rep Infect Dis       Date:  2017-01-17

Review 5.  Epstein-Barr Virus (EBV) acute acalculous cholecystitis in an immunocompromised adult patient: a case report and a literature review of a neglected clinical presentation.

Authors:  Sara Boninsegna; Silvia Storato; Niccolò Riccardi; Marco Soprana; Eugenio Oliboni; Francesca Tamarozzi; Paolo Bocus; Mariano Martini; Annarosa Floreani
Journal:  J Prev Med Hyg       Date:  2021-04-29

6.  Acute Alithiasic Cholecystitis and Human Herpes Virus Type-6 Infection: First Case.

Authors:  Maria Miguel Gomes; Henedina Antunes; Ana Luísa Lobo; Fernando Branca; Jorge Correia-Pinto; João Moreira-Pinto
Journal:  Case Rep Pediatr       Date:  2016-04-20

7.  Another Report of Acalculous Cholecystitis in a Greek Patient with Infectious Mononucleosis: A Matter of Luck or Genetic Predisposition?

Authors:  Theocharis Koufakis; Ioannis Gabranis
Journal:  Case Reports Hepatol       Date:  2016-01-14

Review 8.  Acalculous Acute Cholecystitis in Previously Healthy Children: General Overview and Analysis of Pediatric Infectious Cases.

Authors:  Dimitri Poddighe; Matteo Tresoldi; Amelia Licari; Gian Luigi Marseglia
Journal:  Int J Hepatol       Date:  2015-11-11

9.  A Case Report of Acute Abdominal Pain From a Rare Infectious Etiology.

Authors:  Ramya Deepthi Billa; Eric McGrath
Journal:  Glob Pediatr Health       Date:  2018-07-10

Review 10.  Acute acalculous cholecystitis in children.

Authors:  Dimitri Poddighe; Vitaliy Sazonov
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.